These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37604912)

  • 1. Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth.
    Jin L; Zhu J; Yao L; Shen G; Xue BX; Tao W
    Cell Death Dis; 2023 Aug; 14(8):537. PubMed ID: 37604912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
    Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
    Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth.
    Zhang Y; Cheng L; Shi X; Song Y; Chen XY; Chen MB; Yao J; Zhang ZQ; Cai S
    Int J Biol Sci; 2022; 18(7):2994-3005. PubMed ID: 35541904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-osteosarcoma cell activity by the sphingosine kinase 1 inhibitor SKI-V.
    Sun X; Shan HJ; Yin G; Zhang XY; Huang YM; Li HJ
    Cell Death Discov; 2022 Feb; 8(1):48. PubMed ID: 35115496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNE-493 inhibits prostate cancer cell growth via Akt-mTOR-dependent and -independent mechanisms.
    Jin L; Zhang W; Yao MY; Tian Y; Xue BX; Tao W
    Cell Death Discov; 2022 Mar; 8(1):120. PubMed ID: 35296639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
    Zhang L; Shi X; Zhang L; Mi Y; Zuo L; Gao S
    Cell Death Dis; 2024 Mar; 15(3):204. PubMed ID: 38467612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDC-0349 inhibits non-small cell lung cancer cell growth.
    Yang H; Zhao J; Zhao M; Zhao L; Zhou LN; Duan Y; Li G
    Cell Death Dis; 2020 Nov; 11(11):951. PubMed ID: 33154352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells.
    Yang YL; Ji C; Cheng L; He L; Lu CC; Wang R; Bi ZG
    Cancer Sci; 2012 Aug; 103(8):1538-45. PubMed ID: 22594559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo.
    Xun C; Chen MB; Qi L; Tie-Ning Z; Peng X; Ning L; Zhi-Xiao C; Li-Wei W
    J Exp Clin Cancer Res; 2015 Sep; 34(1):94. PubMed ID: 26337959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
    LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP
    Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro.
    Yao C; Wu S; Li D; Ding H; Wang Z; Yang Y; Yan S; Gu Z
    Mol Oncol; 2012 Aug; 6(4):392-404. PubMed ID: 22583777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
    Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
    Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism.
    Maceyka M; Sankala H; Hait NC; Le Stunff H; Liu H; Toman R; Collier C; Zhang M; Satin LS; Merrill AH; Milstien S; Spiegel S
    J Biol Chem; 2005 Nov; 280(44):37118-29. PubMed ID: 16118219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting sphingosine kinase-1 to inhibit melanoma.
    Madhunapantula SV; Hengst J; Gowda R; Fox TE; Yun JK; Robertson GP
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):259-74. PubMed ID: 22236408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AZD5153 Inhibits Prostate Cancer Cell Growth in Vitro and in Vivo.
    Shen G; Chen J; Zhou Y; Wang Z; Ma Z; Xu C; Jiang M
    Cell Physiol Biochem; 2018; 50(2):798-809. PubMed ID: 30308485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
    Pchejetski D; Golzio M; Bonhoure E; Calvet C; Doumerc N; Garcia V; Mazerolles C; Rischmann P; Teissié J; Malavaud B; Cuvillier O
    Cancer Res; 2005 Dec; 65(24):11667-75. PubMed ID: 16357178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor.
    Zhang D; Xia H; Zhang W; Fang B
    Tumour Biol; 2016 Jan; 37(1):1327-36. PubMed ID: 26293898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
    Deeb D; Gao X; Jiang H; Dulchavsky SA; Gautam SC
    Prostate; 2009 Jun; 69(8):851-60. PubMed ID: 19189297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.
    Gao H; Gao MQ; Peng JJ; Han M; Liu KL; Han YT
    Acta Pharmacol Sin; 2017 Dec; 38(12):1618-1631. PubMed ID: 29119970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic value of SC66 in human renal cell carcinoma cells.
    Xu M; Wang Y; Zhou LN; Xu LJ; Jin ZC; Yang DR; Chen MB; Zhu J
    Cell Death Dis; 2020 May; 11(5):353. PubMed ID: 32393791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.